These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27078730)

  • 1. [The treatment of tuberculosis].
    Degen T; Bregenzer T
    Praxis (Bern 1994); 2016 Apr; 105(8):457-61. PubMed ID: 27078730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2012 Mar; 10(116):29-36; quiz 37-8. PubMed ID: 22450707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy and prognosis of tuberculosis].
    Fischer B; Ferlinz R
    Versicherungsmedizin; 1995 Dec; 47(6):212-6. PubMed ID: 8571498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of tuberculosis].
    Dautzenberg B
    Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance in Mycobacterium tuberculosis.
    Cole ST; Telenti A
    Eur Respir J Suppl; 1995 Sep; 20():701s-713s. PubMed ID: 8590570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of drug-resistant tuberculosis.
    Humma LM
    Am J Health Syst Pharm; 1996 Oct; 53(19):2291-8; quiz 2335-6. PubMed ID: 8893067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
    Weltman AC; Rose DN
    Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Managing the adverse events of antitubercular agents].
    Perriot J; Chambonnet E; Eschalier A
    Rev Mal Respir; 2011 Apr; 28(4):542-55. PubMed ID: 21549908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE; Otaya M; Antoniskis D; Sian S; Wang F; Mercado A; Davidson PT; Barnes PF
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis and nontuberculous mycobacterial infections].
    Wagner D; Kern WV
    Dtsch Med Wochenschr; 2011 Apr; 136(14):691-4. PubMed ID: 21448828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.